AKT1 and breast carcinoma: For instance, in breast cancer research, single-cell sequencing has uncovered key pathway networks driving tumor progression and therapeutic resistance, containing the Wnt–β-catenin, PI3K–AKT, and hypoxia-inducible factor pathways [426].